UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19

Journal of translational medicine, 2020-08, Vol.18 (1), p.322-12, Article 322

2020

Volltextzugriff (PDF)

The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo

PloS one, 2011-06, Vol.6 (6), p.e21077

2011

Volltextzugriff (PDF)

Exosome removal as a therapeutic adjuvant in cancer

Journal of translational medicine, 2012-06, Vol.10 (1), p.134-134, Article 134

2012

Volltextzugriff (PDF)

Aberrant splicing and drug resistance in AML

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.85-85, Article 85

2016

Volltextzugriff (PDF)

FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro

International journal of molecular sciences, 2022-09, Vol.23 (19), p.11387

2022

Volltextzugriff (PDF)

Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia

International journal of molecular sciences, 2024-08, Vol.25 (15), p.8532

2024

Volltextzugriff (PDF)

Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow

Neoplasia (New York, N.Y.), 2021-12, Vol.23 (12), p.1252-1260

2021

Volltextzugriff (PDF)

Application of vitamin D and vitamin D analogs in acute myelogenous leukemia

Experimental hematology, 2017-06, Vol.50, p.1-12

2017

Volltextzugriff (PDF)

Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

Frontiers in oncology, 2023-11, Vol.13, p.1286863-1286863

2023

Volltextzugriff (PDF)

PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy

PloS one, 2011-05, Vol.6 (5), p.e19798-e19798

2011

Volltextzugriff (PDF)

Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability

Biomedicines, 2022-04, Vol.10 (5), p.1038

2022

Volltextzugriff (PDF)

Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells

PloS one, 2011-06, Vol.6 (6), p.e21583

2011

Volltextzugriff (PDF)

Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products

Biomedicines, 2022-06, Vol.10 (6), p.1410

2022

Volltextzugriff (PDF)

Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia

Biomedicines, 2024-10, Vol.12 (10), p.2250

2024

Volltextzugriff (PDF)

Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma

British journal of haematology, 2014-09, Vol.166 (6), p.920-928

2014

Volltextzugriff (PDF)

Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4718-4726

2009

Volltextzugriff (PDF)

Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype

PloS one, 2013-08, Vol.8 (8), p.e70891

2013

Volltextzugriff (PDF)

Metastatic biomarkers in synovial sarcoma

Biomarker research, 2017-02, Vol.5 (1), p.4-4, Article 4

2017

Volltextzugriff (PDF)

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

British journal of haematology, 2011-12, Vol.155 (5), p.580-587

2011

Volltextzugriff (PDF)

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside

Journal of hematology and oncology, 2009-07, Vol.2 (1), p.33-33, Article 33

2009

Volltextzugriff (PDF)

High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway

OncoTargets and therapy, 2016-01, Vol.9, p.4887-4899

2016

Volltextzugriff (PDF)

Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest

Oncotarget, 2016-09, Vol.7 (38), p.61081-61092

2016

Volltextzugriff (PDF)

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature

Journal of hematology and oncology, 2010-03, Vol.3 (1), p.12-12, Article 12

2010

Volltextzugriff (PDF)

Differential remodeling of extracellular matrices by breast cancer initiating cells

Journal of biophotonics, 2015-10, Vol.8 (10), p.804-815

2015

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(108)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19

The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo

Exosome removal as a therapeutic adjuvant in cancer

Aberrant splicing and drug resistance in AML

FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro

Discovery of NFκB2-Coordinated Dual Regulation of Mitochondrial and Nuclear Genomes Leads to an Effective Therapy for Acute Myeloid Leukemia

Ex vivo isolation, expansion and bioengineering of CCR7+CD95-/or CD62L+CD45RA+ tumor infiltrating lymphocytes from acute myeloid leukemia patients’ bone marrow

Application of vitamin D and vitamin D analogs in acute myelogenous leukemia

Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro

PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapy

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study

Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability

Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells

Targeting the Tumor Microenvironment in Acute Myeloid Leukemia: The Future of Immunotherapy and Natural Products

Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia

Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma

Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies

Akt-induced phosphorylation of N-CoR at serine 1450 contributes to its misfolded conformational dependent loss (MCDL) in acute myeloid leukemia of the M5 subtype

Metastatic biomarkers in synovial sarcoma

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside

High expression of S100A8 gene is associated with drug resistance to etoposide and poor prognosis in acute myeloid leukemia through influencing the apoptosis pathway

Novel B55α-PP2A mutations in AML promote AKT T308 phosphorylation and sensitivity to AKT inhibitor-induced growth arrest

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature

Differential remodeling of extracellular matrices by breast cancer initiating cells

Suchergebnisse filtern